Inozyme Pharma, Inc. Annual Operating Lease, Payments in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Inozyme Pharma, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2020 to 2022.
  • Inozyme Pharma, Inc. Operating Lease, Payments for the quarter ending March 31, 2021 was $200K.
  • Inozyme Pharma, Inc. annual Operating Lease, Payments for 2022 was $900K, unchanged from 2021.
  • Inozyme Pharma, Inc. annual Operating Lease, Payments for 2021 was $900K, a 50% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $900K $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-22
2021 $900K +$300K +50% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $600K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.